You are here

Hawaii Biotech, Inc.

Company Information
Address
650 Iwilei Rd Ste 204
Honolulu, HI 96817-5318
United States



Information

UEI: ECJKEEFL4L51

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. BISPECIFIC ANTIBODY FOR DIRECTED DELIVERY OF PALYTOXIN

    Amount: $50,000.00

    CONSIDERABLE INTEREST HAS BEEN FOCUSSED ON THE PRODUCTION AND CHARACTERIZATION OF THERAPEUTIC IMMUNOCONJUGATES. SUCH HYBRID MOLECULES USUALLY CONSIST OF A MONOCLONAL ANTIBODY WITH COVALENTLY ATTACHED ...

    SBIRPhase I1991Department of Health and Human Services
  2. COFFEE ALPHA-GALACTOSIDASE CDNA CLONING FOR BLOOD PROCESSING

    Amount: $50,000.00

    IT HAS BEEN DEMONSTRATED THAT ALPHA-GALACTOSIDASE AND ALPHA-N-ACETYL GALACTOSAMINIDASE HAVE THE ABILITY TO ENZYMATICALLY CONVERT TYPE B AND A HUMAN ERYTHROCYTES, RESPECTIVELY, TO SEROTYPICALLY TYPE O ...

    SBIRPhase I1991Department of Health and Human Services
  3. UREASE-LINED IMMUNOASSAY REAGENT STABILITY STUDIES

    Amount: $53,000.00

    N/A

    SBIRPhase I1991Department of Defense Army
  4. MINIATURIZED FT-IR SENSOR FOR INFRARED MEASUREMENTS

    Amount: $53,228.00

    N/A

    SBIRPhase I1991Department of Defense Navy
  5. PALYTOXIN PRODRUG ACTIVATION BY ANTIBODY-LINKED ENZYME

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  6. EXPRESSION OF DENGUE 3 ENVELOPE AND NONSTRUCTURAL 1 GLYCOPROTEINS IN THE FUNGUS NEUROSPORA CRASSA

    Amount: $67,723.00

    THE FOUR SEROTYPES OF DENGUE VIRUSES ARE A LEADING CAUSE OF MORBIDITY THROUGHOUT THE TROPICS AND SUBTROPICS. FOR THE DEVELOPMENT OF DIAGNOSTICS FOR AND SUBUNIT VACCINES AGAINST DENGUE VIRUS, A RELIABL ...

    SBIRPhase I1990Department of Defense Army
  7. CLONING AND EXPRESSION OF RECOMBINANT HTLV-II ENVELOPE PROTEIN IN E. COLI

    Amount: $50,000.00

    HUMAN T-LYMPHOTROPIC VIRUS TYPE II (HTLV-II) IS A HUMAN RETROVIRUS RELATED TO, BUT DISTINCT FROM, OTHER RETROVIRUSESTHAT ARE IDENTIFIED CAUSATIVE AGENTS OF DISEASE. LITTLE IS KNOWN ABOUT HTLV-II PREVA ...

    SBIRPhase I1990Department of Health and Human Services
  8. IMMUNOASSAYS FOR TAXOL

    Amount: $48,659.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  9. IMMUMOASSAYS FOR DIDEMNINS

    Amount: $50,000.00

    THE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP IMMUNOASSAYS CAPABLE OF DETECTING DIDEMNINS AT THE NANOGRAM LEVEL. DIDEMNIN B IS THE MOST POTENT ANTITUMOR, ANTIVIRAL, AND CYTOTOXIC MEMBER OF A FAMILY O ...

    SBIRPhase I1989Department of Health and Human Services
  10. ORGANIC PHASE IMMUNOCHEMISTRY

    Amount: $50,000.00

    IMMUNOCHEMICAL TECHNIQUES HAVE MANY DIVERSE APPLICATIONS. HOWEVER, THEY ARE RESTRICTED TO USE ONLY IN AQUEOUS MEDIA. ECONOMICAL TECHNIQUES FOR DIRECT ORGANIC PHASE ANALYSIS AND IMMUNOAFFINITY ISOLATIO ...

    SBIRPhase I1989National Science Foundation
US Flag An Official Website of the United States Government